Other studies conducted in GBM U87MG and U251 cells demonstrated that the blockade of Sema3B-targeted miRNA miR-221 led to an upregulation of Sema3B protein levels, which was associated with decreased cancer cell proliferation [31]. The gene discussed is SEMA3B; the disease is cancer.